Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
B.1.1.266NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
B.1.177.12NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
AY.4.5 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
B.1.499.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
B.1.1.63NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
B.1.578NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
MM.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
XBB.2.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
JN.1.16.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
AY.112.2 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
B.1.1.389NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
B.1.1.322NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
B.1.139NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18959Hong Kong
C.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-18962Germany
BA.2.3.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-18962Germany
C.2.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-18962Germany
GJ.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18993.8US
B.1.177.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19006.2Thailand
C.21NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19006.2Thailand
B.1.438.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.328NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.1.214NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.618NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
AZ.2.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.625NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.633NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2.5.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.438.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.429.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.588NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
C.23NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
P.2 (Zeta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.360NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.1.397NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.429 (Epsilon)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.36.21NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.30NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
AZ.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.561NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.585NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.1.486NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2.5.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.523NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2.5.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.460NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.623SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-19036.1Japan
AY.120.1 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19039.3China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used